about
Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics.Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia.Cytochrome P450 1A2 co-determines neuroleptic load and may diminish tardive dyskinesia by increased inducibility.[The association of the DRD3 gene with Parkinson's disease][The role of reamberin in combined therapy of abstinence syndrome in alcoholics]Cortisol and DHEAS Related to Metabolic Syndrome in Patients with SchizophreniaAssociation of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia
P50
Q40518115-17F9DDBA-FA46-4014-8BCE-88A4409398B0Q40571585-E3A1241E-6A84-4E2E-9249-96D8E95326BBQ50600844-05DA9C4F-8B9F-43D5-B21F-0904F2C93B87Q62926209-BBCD024E-8EA9-4FA3-B15F-285B6E6696F8Q62926523-94370F4E-EC04-4C46-BE1B-D969427833EAQ94525694-0BC7FCD5-AE92-4815-9FCF-BAFD528BAC66Q94561580-B980D276-F2F9-4844-8ED7-70F283790166
P50
description
investigador
@es
researcher
@en
name
A S Boĭko
@en
type
label
A S Boĭko
@en
prefLabel
A S Boĭko
@en
P31
P496
0000-0002-2955-9057